Analysis of 47 Patients with Triple Negative (ER, PGR, HER2) Breast Cancer

Gunes M. E., Celik G., Trabulus F. D., Aksoy S., Ozoran E., Aren A., ...More

ISTANBUL MEDICAL JOURNAL, vol.13, no.4, pp.166-168, 2012 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 13 Issue: 4
  • Publication Date: 2012
  • Doi Number: 10.5505/1304.8503.2012.96158
  • Journal Name: ISTANBUL MEDICAL JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.166-168
  • Keywords: HER2, breast cancer, estrogene receptor, progesterone receptor
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Objectives: Breast cancer is the most common cancer in women. Breast cancer responds variable depending on morphological, clinical, hormonal receptor level differences. In current medical practice ER, PGR, HER2 levels have been important prognostic factors changing the outcome and the treatment modalities.